Search research articles
Contact Us
Filters
Showing results (61-70 of 86) with videos related to
Page
of 9
Sort By:
Leukemia
|
January 31, 2013
Perifosine and sorafenib combination induces mitochondrial cell death and antitumor effects in NOD/SCID mice with Hodgkin lymphoma cell line xenografts
S L Locatelli, A Giacomini, A Guidetti, et al.
The Journal of Experimental Medicine
|
September 22, 1998
Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage
R Lupetti, P Pisarra, A Verrecchia, et al.
Experimental Hematology
|
December 1, 1995
Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy
S Siena, M Di Nicola, M Bregni, et al.
Cancer Research
|
August 1, 1995
Overexpression of the T-cell receptor beta-chain variable region TCRBV14 in HLA-A2-matched primary human melanomas
S Salvi, F Segalla, S Rao, et al.
The Journal of Experimental Medicine
|
October 1, 1993
T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone
M Sensi, S Salvi, C Castelli, et al.
Cancer Research
|
April 15, 1991
Heterogeneity in human melanoma cell adhesion to cytokine activated endothelial cells correlates with VLA-4 expression
I Martìn-Padura, R Mortarini, D Lauri, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 1, 1990
Gene transfer by retrovirus-derived shuttle vectors in the generation of murine bispecific monoclonal antibodies
L B DeMonte, P Nistico, R Tecce, et al.
Cancer Research
|
January 4, 1998
Autologous dendritic cells derived from CD34+ progenitors and from monocytes are not functionally equivalent antigen-presenting cells in the induction of melan-A/Mart-1(27-35)-specific CTLs from peripheral blood lymphocytes of melanoma patients with low frequency of CTL precursors
R Mortarini, A Anichini, M Di Nicola, et al.
The Journal of Clinical Investigation
|
September 1, 1992
Cell retargeting by bispecific monoclonal antibodies. Evidence of bypass of intratumor susceptibility to cell lysis in human melanoma
P Nisticò, R Mortarini, L B De Monte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Pilot study of subcutaneous recombinant human interleukin 12 in metastatic melanoma
E Bajetta, M Del Vecchio, R Mortarini, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 86) with videos related to
Sort By:
Page
of 9
Leukemia
|
January 31, 2013
Perifosine and sorafenib combination induces mitochondrial cell death and antitumor effects in NOD/SCID mice with Hodgkin lymphoma cell line xenografts
S L Locatelli, A Giacomini, A Guidetti, et al.
The Journal of Experimental Medicine
|
September 22, 1998
Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage
R Lupetti, P Pisarra, A Verrecchia, et al.
Experimental Hematology
|
December 1, 1995
Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy
S Siena, M Di Nicola, M Bregni, et al.
Cancer Research
|
August 1, 1995
Overexpression of the T-cell receptor beta-chain variable region TCRBV14 in HLA-A2-matched primary human melanomas
S Salvi, F Segalla, S Rao, et al.
The Journal of Experimental Medicine
|
October 1, 1993
T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone
M Sensi, S Salvi, C Castelli, et al.
Cancer Research
|
April 15, 1991
Heterogeneity in human melanoma cell adhesion to cytokine activated endothelial cells correlates with VLA-4 expression
I Martìn-Padura, R Mortarini, D Lauri, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 1, 1990
Gene transfer by retrovirus-derived shuttle vectors in the generation of murine bispecific monoclonal antibodies
L B DeMonte, P Nistico, R Tecce, et al.
Cancer Research
|
January 4, 1998
Autologous dendritic cells derived from CD34+ progenitors and from monocytes are not functionally equivalent antigen-presenting cells in the induction of melan-A/Mart-1(27-35)-specific CTLs from peripheral blood lymphocytes of melanoma patients with low frequency of CTL precursors
R Mortarini, A Anichini, M Di Nicola, et al.
The Journal of Clinical Investigation
|
September 1, 1992
Cell retargeting by bispecific monoclonal antibodies. Evidence of bypass of intratumor susceptibility to cell lysis in human melanoma
P Nisticò, R Mortarini, L B De Monte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Pilot study of subcutaneous recombinant human interleukin 12 in metastatic melanoma
E Bajetta, M Del Vecchio, R Mortarini, et al.
Page
of 9